$GOOGL

Alphabet To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday - Alphabet (NASDAQ:GOOGL),

Analysts updated price targets for several companies. UBS raised Vertex's (VRTX) target to $615, Melius cut McDonald's (MCD) to $230, and Piper Sandler increased Alphabet's (GOOGL) target to $400. Other notable changes include Okta (OKTA), AutoZone (AZO), Vaxcyte (PCVX), Camping World (CWH), Copart (CPRT), Delta (DAL), and Fiserv (FISV).

Original reporting
Published Sep 28, 2026, 6:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 7:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$GOOGL
Bullish
medium confidence
Mentioned
$GOOGL · $VRTX · $MCD · $OKTA · $AZO · $PCVX
Relevance
5/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$GOOGLBullishLow
01

Why it matters

While the target changes provide fresh analyst sentiment, they are incremental and lack a single material catalyst, resulting in limited immediate trading opportunities.

02

Market read

Analyst target revisions may cause modest reallocation among the listed stocks but are unlikely to drive significant market moves.

03

What to watch

Potential macro backdrop or earnings trends not discussed could influence the real impact of these revisions.

Relevance 5/10Novelty 3/10Timing: after market close

Background

The article aggregates recent analyst price target adjustments for a set of U.S.-listed companies, including Alphabet, following routine coverage updates.

Company-level read

Ticker impact

$GOOGLBullishMedium confidence
Context

Piper Sandler raised Alphabet's price target to $400 from $395.

Expected impact

likely slight upward pressure as investors price in higher target

Evidence & confidence

Analyst upgrade with a modest target increase may attract buying interest.

$VRTXBullishMedium confidence
Context

UBS raised Vertex Pharmaceuticals' price target to $615 from $585.

Expected impact

potential modest upside as market absorbs higher valuation

Evidence & confidence

Analyst maintains Buy rating with a higher target, supporting price appreciation.

$MCDBearishMedium confidence
Context

Melius Research cut McDonald's price target to $230 from $250.

Expected impact

likely downward pressure as investors reassess valuation

Evidence & confidence

Sell rating with lower target may prompt profit‑taking.

$OKTABullishMedium confidence
Context

Scotiabank raised Okta's price target to $245 from $190.

Expected impact

possible upside as market prices in higher expectations

Evidence & confidence

Large upward revision may attract new buying interest.

$AZOBearishMedium confidence
Context

JP Morgan lowered AutoZone's price target to $3,700 from $3,850.

Expected impact

potential modest downside pressure

Evidence & confidence

Overweight rating remains but lower target may temper enthusiasm.

$PCVXNeutralLow confidence
Context

B of A Securities cut Vaxcyte's price target to $130 from $133.

Expected impact

likely little immediate price movement

Evidence & confidence

Small adjustment unlikely to move the stock materially.

$CWHBearishMedium confidence
Context

Roth Capital lowered Camping World's price target to $10 from $12.

Expected impact

possible downward pressure

Evidence & confidence

Lower target may trigger selling pressure.

$CPRTBullishMedium confidence
Context

BNP Paribas raised Copart's price target to $43 from $40.

Expected impact

potential modest upside

Evidence & confidence

Higher target may encourage buying interest.

Market effects

Analyst target revisions across tech, consumer, and industrials may slightly shift sector sentiment.

U.S. equity market may see modest rebalancing as investors adjust positions based on new targets.

Limited; primarily affects U.S.-listed equities.

Counterpoint

Target changes are modest and may be already priced in; traders could wait for stronger catalysts.

Key entities

  • Alphabet Inc.

    Subject of price target raise by Piper Sandler.

  • Vertex Pharmaceuticals

    Target raised by UBS.

  • McDonald's

    Target lowered by Melius Research.

Related articles

$GOOGLMed

Alphabet Unveils Gemini 4 Argon AI Model for Advanced Professional Tasks

Alphabet (GOOGL) introduced Gemini 4 Argon, its most advanced AI model, excelling in coding, cybersecurity, and professional tasks. The model is already used internally to optimize data centers. Alphabet's Q2 revenue grew 24% to $119.8B, with Google Cloud revenue up 82%. The company raised its 2026 capital spending guidance to $195B-$205B. GOOGL stock is up 16% in 6 months, with a $429 price target.

$CPRTHighAI 8/10

Copart Extends $10.50-Per-Share Tender Offer for ACV Auctions

Copart extended its $10.50-per-share tender offer for ACV Auctions until October 7, awaiting federal antitrust review. As of September 30, 47.78% of ACV shares were tendered, below the 50% threshold. The acquisition aims to combine their digital automotive marketplaces, with regulatory clearance pending.